Antibiotic polymethylmethacrylate bone cement
AssigneeHeraeus Medical GmbH
InventorsSEBASTIAN VOGT, SUSANN KLIMAS
Life of this patent
Estimating the term…
Loading patent…
AssigneeHeraeus Medical GmbH
InventorsSEBASTIAN VOGT, SUSANN KLIMAS
Estimating the term…
An antibiotic polymethylmethacrylate bone cement that is composed of methylmethacrylate, at least one polymethylmethacrylate or a polymethylmethacrylate-copolymer, at least one polymerisation initiator, such as in radical initiator, at least one polymerisation accelerator, and at least one radiopaquer, whereby the components are present in a powdered component and a liquid monomer component or in two components that are pasty at room temperature. The polymethylmethacrylate bone cement comprises the cyclical lipopeptide, daptomycin, a pharmacologically tolerable salt of daptomycin, a solvate and/or a hydrate containing daptomycin and at least one calcium salt, which preferably comprises at least two different release profiles. The bone cement is useful in one-stage or two-stage septic revision surgery.
A method of conducting a one-stage or two-stage septic revision surgery, said method comprising anchoring a revision articular endoprosthesis in an area within the human body with an antibiotic bone cement, wherein the antibiotic bone cement is prepared by polymerizing an antibiotic polymerizable bone cement comprising:
A method of conducting a one-stage or two-stage septic revision surgery, said method comprising removing an infected articular endoprosthesis from an area within the human body and temporarily introducing a spacer into that area, wherein the spacer is composed of an antibiotic bone cement prepared by polymerizing an antibiotic polymerizable bone cement comprising:
Dependencies are inferred from the claim text.